New injection slows down early puberty in kids

NCT ID NCT05341115

First seen Jan 23, 2026 · Last updated May 10, 2026 · Updated 19 times

Summary

This study tested a drug called leuprorelin in 80 children with central precocious puberty, a condition where puberty starts too early. The treatment is an injection given every 12 weeks for 6 months. The goal was to see if it could suppress puberty hormones and slow down physical development. The study found that the drug helped control early puberty, but children may need ongoing treatment to manage the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL PRECOCIOUS PUBERTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100033, China

  • Provincial Hospital Affiliated to Shandong First Medical University

    Jinan, Shandong, 250021, China

  • Shanghai Children's Hospital

    Shanghai, Shanghai Municipality, 200062, China

  • The Hospital attached by the Torigji Medical College, Huazhong Science and Technology University.

    Wuhan, Hubei, 430030, China

  • the First A liated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510062, China

Conditions

Explore the condition pages connected to this study.